Overview
Description
Susmed Inc. is a pioneering healthcare technology company specializing in the development of digital therapeutics. Digital therapeutics involve the use of software to deliver evidence-based therapeutic interventions to patients in order to prevent, manage, or treat diseases and medical disorders. Susmed's offerings aim to enhance healthcare delivery by integrating advanced technology with traditional medical practices, thereby optimizing patient outcomes and expanding access to treatments.
The company's innovations are particularly impactful in the management of chronic diseases and mental health conditions, leveraging mobile applications and wearable technology to monitor and improve patient health remotely. Its contributions are vital in industries focused on healthcare digitization, telemedicine, and personalized medicine.
In the financial markets, Susmed Inc. plays a significant role as an embodiment of the increasing intersection between technology and healthcare, attracting attention from investors interested in the evolving landscape of health tech solutions. The company's focus on sustainability and efficacy in healthcare provision highlights its importance as a key player in not only the improvement of patient care but also the enhancement of healthcare systems worldwide.
About
CEO
Mr. Taro Ueno
Employees
43
Address
MFPR Nihonbashi honcho Bldg
10th Floor 3-7-2 Nihonbashi honcho Chuo-ku
Tokyo, 103-0023
10th Floor 3-7-2 Nihonbashi honcho Chuo-ku
Tokyo, 103-0023
Phone
86 3 6366 7780
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Health Information Services
Country
Japan
MIC code
XJPX